Trial Profile
Efficacy of busulfan with pharmacokinetic-guided dose adjustment as conditioning regimen in patients with acute myeloid leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2014
Price :
$35
*
At a glance
- Drugs Busulfan (Primary) ; Cyclophosphamide; Methotrexate
- Indications Acute myeloid leukaemia; Graft-versus-host disease
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 15 Oct 2014 New trial record